📰 Confidence Interval News
Page 18 - Confidence Interval News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Confidence Interval. Real-time updates on events, politics, business and more.
October 9, 2023
A study presented at HFSA 2023 offers clinicians an overview of the influence of socioeconomic status on access to implantable hemodynamic monitors using the National Inpatient Sample.
October 9, 2023
1. The GI-Genius neural network system did not improve the rate of detecting advanced colorectal neoplasia by colonoscopy in patients with a first positive fecal immunochemical test (FIT). 2. The unassisted control group had a high adenoma detection rate (ADR) at baseline. Evidence Rating Level: 1 (Excellent) Study Rundown: Colorectal cancer (CRC) screening, involving FIT
October 7, 2023
A propensity score-matched analysis of data suggests use of spironolactone could reduce the 3-year risk of developing Alzheimer disease or dementia among patients with heart failure with reduced ejection fraction.
October 6, 2023
RBI Monetary Policy: The Indian central banks growth forecast for 2024-25 assumes a normal monsoon and no major exogenous or policy shocks next year
October 5, 2023
Welcome to the 2 Minute Medicine Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in healthcare news and research evidence. Our episode is live! Episode Description We begin this episode by discussing our article of the week from the New England
October 5, 2023
1. In this randomized controlled trial, complete revascularization reduced the risk of myocardial infarction, stroke, or ischemia-driven revascularization at one year in patients with myocardial infarction compared to culprit lesion revascularization. 2. There was no difference in safety outcomes, including acute kidney injury, stroke, or bleeding, between groups. Evidence Rating Level: 1 (Excellent) Study Rundown:
September 29, 2023
A study from UCLA suggests a pharmacist-led intervention contributed to improved HbA1c in Hispanic adults with type 2 diabetes management, underlining its potential to enhance outcomes in underserved populations.
September 25, 2023
A network meta-analysis suggests tirzepatide may be more effective than semaglutide in reducing HbA1c and body weight in type 2 diabetes but may increase gastrointestinal adverse events, especially at higher doses.
September 25, 2023
A study on juvenile idiopathic arthritis emphasizes early initiation of biologic treatment for better long-term outcomes, as delayed treatment is linked to greater physical disability and worse quality of life in adulthood.
September 23, 2023
Elevated serum endotrophin levels, but not urinary endotrophin levels, predict increased risk of kidney complications and mortality in type 1 diabetes.